Q-omics provides the consensus-scored MIR526B profile across patient tissues and cancer cell-line models. MIR526B expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LUAD. Additionally, MIR526B RNA expression shows 6,189 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUAD, and STAD as cancer lineages where MIR526B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR526B — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MIR526B survival associations across molecular data types. MIR526B RNA expression shows survival associations in the most cancer types (6), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR526B data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	LUAD (144)	view →
Mutation	Kaplan–Meier	1	SKCM (17)	view →

This table ranks reproducible MIR526B RNA expression–survival associations across cancer types. High MIR526B expression shows unfavorable associations in LUAD, BLCA, CESC, KIRC and SKCM, but favorable associations in STAD. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for MIR526B RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.109	0.835	<.001	144	view →
BLCA	DFS	Tertile	III,IV	0.200	0.555	<.001	108	view →
CESC	OS	Tertile	All	0.167	0.798	<.001	90	view →
KIRC	DFS	Tertile	II,III,IV	0.166	0.768	<.001	42	view →
STAD	OS	Tertile	IV	1.000	0.277	.023	36	view →
SKCM	OS	Tertile	III,IV	0.548	0.811	.007	12	view →

Pink = unfavorable, green = favorable. all 6 lineages →

MIR526B-LUAD (OS)

Kaplan–Meier survival curve for MIR526B RNA expression in LUAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MIR526B in patient tissues and cancer cell lines. In patient samples, MIR526B shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,189	STAD (5952)	view →
RNA	4,220	STAD (1678)	view →
▼Mutation
RNA	18	SKCM (18)	view →